Gout Highlights

• Abstract 518: Placebo-Controlled Pilot Study of Rilonacept (IL-1 Trap), A Long Acting IL-1 Inhibitor, In Refractory Chronic Active Gouty Arthritis
• Abstract 755: Mouse IL-1 Trap Reduces Pain and Inflammation in Animal Models of Gout
• Abstract 757: Urate-Lowering Therapy (Febuxostat [FEB] or Allopurinol [ALLO]) in Subjects with Gout: Interim Results from the Febuxostat Comparative Extension Long-Term Study (EXCEL)
• Abstract 758: Gout Flare Incidence in Relation to Average Serum Urate during the First Year of Urate-Lowering Therapy
• Abstract #756 Disordered Osteoclast Development in Patients with Tophaceous Gout; Uric Acid Crystals Promote Osteoclastogenesis Through Interactions with Stromal Cells

All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.